Evidence map›Paper›PMID 42402435›Full record

ArticlePublic health reports (Washington, D.C. : 1974)2026

Public Awareness and Acceptance of Wastewater Surveillance in the United States, June 2024.

Rieza H Soelaeman, Diana Valencia, Libby Horter, Hannah Turner, Rajesh Yadav, Kathleen M Tatti, Emily Nelson, Manpreet Kaur, Deanna Amarosa, B Casey Lyons and 4 more

Abstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rieza H SoelaemanDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-3505-2559
Diana ValenciaDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-9578-3751
Libby HorterDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-2503-1690
Hannah TurnerDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-5314-628X
Rajesh YadavDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-4451-3986
Kathleen M TattiDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-9414-7887
Emily NelsonDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0009-0005-5483-8129
Manpreet KaurDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Deanna AmarosaDivision of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0009-0007-2661-8086
B Casey LyonsDivision of Overdose Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-7101-1581
Michael WeltonDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Souci LouisDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0009-0005-9754-8279
Jena LoschDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-8798-3307
Scott SantibañezDivision of Infectious Disease Readiness and Innovation, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-3505-8176

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectivesWastewater surveillance (WWS) is a valuable public health tool for monitoring infectious diseases. Recent studies suggest its potential for monitoring opioids or other drugs. We evaluated WWS awareness and public acceptance of WWS for respiratory and vector-borne diseases and opioids in the US population.

methodsWe conducted a nationwide cross-sectional survey in June 2024 among US adults aged ≥18 years. We used quantitative analysis (N = 2024) to assess associations between participants' awareness of and attitudes toward WWS, including how those data should be used. We performed qualitative analysis to identify themes among participants who provided comments about opioids or other illicit drugs (n = 67).

resultsOverall, more than half of participants expressed comfort with WWS for respiratory diseases (54.1%), mosquito-borne diseases (57.3%), and opioids or other drugs (51.1%). These percentages were significantly higher (

conclusionsComfort with WWS activities was higher among those who were aware of WWS than among those who were not. Future efforts could focus on improving public awareness and knowledge of how wastewater data are collected and used to benefit public health.

Indexed as

mixed methodsopioidspublic opinionrespiratory diseasevector-borne diseasewastewater surveillance

Identifiers

PMID42402435
PMCPMC13337563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.